PuSH - Publikationsserver des Helmholtz Zentrums München: Trends in oral contraceptive use in a Southern German population: Results of the MONICA project augsburg: Surveys 1984/85 and 1989/90.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Döring, A. ; Filipiak, B. ; Stieber, J. ; Keil, U.

Trends in oral contraceptive use in a Southern German population: Results of the MONICA project augsburg: Surveys 1984/85 and 1989/90.

Eur. J. Public Health 3, 177-180 (1993)

Verlagsversion

DOI

	Open Access Gold

Abstract
Metriken
Zusatzinfos

In the surveys of the MONICA project Augsburg, conducted in 1984/85 (S1) and 1989/90 (S2), data on oral contraceptive (OC) use were gathered in two independent representative population-based samples of women aged 25-44 years (medication history over the previous seven days). OCs were categorized according to their oestrogen content (< 50mg, ≥50mg) and according to their progestogen component. The prevalence of OC use was unchanged between the two points in time (23.4% in S1 and 23.7% in S2). OCs with low oestrogen content were used in 49.0% of the OC users in S1 and in 76.6% in S2. The use of the progestogen component changed also: norethindrone (acetate), levonorgestrel, and lynestrenol were used less, desogestrel more often in S2. Gestoden and norgestimate were used by 15% of the OC users in S2. In conclusion, we can say that there was no change in the prevalence of OC use in the study population; however, a change in hormone content towards preparations with lower hormone content was observed.

Impact Factor

Scopus SNIP

Altmetric

0.000